期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
亚临床甲状腺疾病孕妇的心血管疾病风险因子在早孕及晚孕期的比较分析 被引量:5
1
作者 陈郁钢 贾彤 +5 位作者 沈菊英 金萍 魏峰 朱燕 刘凌 闵燕 《实验与检验医学》 CAS 2015年第5期560-562,共3页
目的观察亚临床甲状腺疾病孕妇的心血管疾病相关因子情况。方法本文为前瞻病例对照研究。研究对象来自2012年7月1日至2013年6月30日在苏州太仓市城乡4家医疗机构及社区建档进行系统检查且在本地分娩的1540例单胎初产孕妇,使用罗氏电化... 目的观察亚临床甲状腺疾病孕妇的心血管疾病相关因子情况。方法本文为前瞻病例对照研究。研究对象来自2012年7月1日至2013年6月30日在苏州太仓市城乡4家医疗机构及社区建档进行系统检查且在本地分娩的1540例单胎初产孕妇,使用罗氏电化学发光自设的早孕期促甲状腺激素(TSH)及游离甲状腺素(FT4)特异性区间筛选,亚临床甲状腺功能亢进(L-TSH)80例,亚临床甲状腺功能减退(H-TSH)48例,选择同期筛查的160例为对照组(N-TSH),分别于早孕(6-12+6周)及晚孕期(28-28+6周)观察其体重、血压、血脂和血糖,并进行比较分析。结果 L-TSH 80例(8.1%,80/1540),H-TSH 48例(3.1%,48/1540),早孕期及晚孕期,三组的总胆固醇(TC)及低密度脂蛋白(LDL-C)均有统计学意义(P〈0.01),H-TSH早孕期TC较对照组为低,而L-TH早孕期较之为高,晚孕期两组间已无明显差异。晚孕期三组的体重、体重增幅、收缩压和舒张压有统计学意义(P〈0.05),L-TSH体重增幅低于对照组,H-TSH体重增幅高于对照组;晚孕期H-TSH和L-TSH两组收缩压、舒张压均高于对照组,以H-TSH为明显;早孕期收缩压和舒张压无统计学意义。结论使用妊娠期甲状腺功能指标的特异性区间进行筛查是判断亚临床甲状腺疾病的重要工作基础,这一疾病对孕期血脂、血压、体重增长有不良的促进作用。 展开更多
关键词 妊娠 妊娠期亚临床甲状腺疾病 心血管病风险因子
下载PDF
Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease 被引量:56
2
作者 Masahide Hamaguchi Takao Kojima +10 位作者 Noriyuki Takeda Chisato Nagata Jun Takeda Hiroshi Sarui Yutaka Kawahito Naohisa Yoshida Atsushi Suetsugu Takahiro Kato Junichi Okuda Kazunori Ida Toshikazu Yoshikawa 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第10期1579-1584,共6页
AIM:To clarify whether nonalcoholic fatty liver disease(NAFLD)increases the risk of cardiovascular disease.METHODS:We carried out a prospective observational study with a total of 1637 apparently healthy Japanese men ... AIM:To clarify whether nonalcoholic fatty liver disease(NAFLD)increases the risk of cardiovascular disease.METHODS:We carried out a prospective observational study with a total of 1637 apparently healthy Japanese men and women who were recruited from a health check-up program.NAFLD was diagnosed by abdominal ultrasonography.The metabolic syndrome(MS)was defined according to the modified National Cholesterol Education Program(NCEP)ATP Ⅲ criteria.Five years after the baseline evaluations,the incidence of cardiovascular disease was assessed by a self-administered questionnaire.RESULTS:Among 1221 participants available for outcome analyses,the incidence of cardiovascular disease was higher in 231 subjects with NAFLD at baseline(5 coronary heart disease,6 ischemic stroke,and 1 cerebral hemorrhage)than 990 subjects without NAFLD(3 coronary heart disease,6 ischemic stroke,and 1 cerebral hemorrhage).Multivariate analyses indicated that NAFLD was a predictor of cardiovascular disease independent of conventional risk factors(odds ratio 4.12,95% CI,1.58 to 10.75,P = 0.004).MS was alsoindependently associated with cardiovascular events.But simultaneous inclusion of NAFLD and MS in a multivariate model revealed that NAFLD but not MS retained a statistically significant correlation with cardiovascular disease.CONCLUSION:Although both of them were predictors of cardiovascular disease,NAFLD but not MS retained a statistically significant correlation with cardiovascular disease in a multivariate model.NAFLD is a strong predictor of cardiovascular disease and may play a central role in the cardiovascular risk of MS. 展开更多
关键词 Nonalcoholic fatty liver disease Metabolic syndrome Coronary heart disease Cardiovascular disease Risk factors
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部